Invesco Nasdaq Biotechnology ETF Rating $22.64 +0.35 (+1.57%) (As of 11/22/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.69Holdings in IBBQ have an aggregate rating of Moderate Buy based on 756 analyst ratings issued in the past year covering 50 companies (80.7% of the portfolio).IBBQ Aggregate Price Target$22.64High Prediction$22.64Average Prediction$22.64Low Prediction$22.64Holdings in IBBQ have an aggregate price target of $22.64 and a range of $22.64 to $22.64 covering 50 companies (80.7% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy34 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.90%GILDGilead Sciences$90.19+0.5%4.6038 of 5 stars2.65$95.41 5.8%26Analyst ForecastAnalyst RevisionNews CoveragePositive News8.03%VRTXVertex Pharmaceuticals$450.97+0.1%4.0653 of 5 stars2.55$504.38 11.8%29Analyst DowngradeAnalyst RevisionPositive News7.62%AMGNAmgen$294.53+1.6%4.9185 of 5 stars2.46$333.57 13.3%26Analyst RevisionPositive News5.53%REGNRegeneron Pharmaceuticals$738.00-0.9%4.8114 of 5 stars2.78$1,099.55 49.0%23Positive News3.94%AZNAstraZeneca$65.63+2.1%3.8821 of 5 stars2.92$89.75 36.8%12Analyst UpgradeAnalyst RevisionGap Up3.42%ALNYAlnylam Pharmaceuticals$244.89-0.8%4.4235 of 5 stars2.71$298.09 21.7%24Analyst Forecast2.44%BIIBBiogen$157.90-0.1%4.8716 of 5 stars2.54$257.20 62.9%28Analyst Forecast2.24%ILMNIllumina$140.14+2.3%4.5994 of 5 stars2.67$164.00 17.0%24Positive News2.04%ARGXargenx$605.92+1.5%2.7629 of 5 stars2.91$630.42 4.0%23Analyst ForecastAnalyst RevisionNews Coverage1.74%UTHRUnited Therapeutics$372.89+1.5%4.5326 of 5 stars2.73$370.86 -0.5%15Insider TradeAnalyst RevisionPositive News1.68%VTRSViatris$13.37+1.8%1.4394 of 5 stars2.00$13.33 -0.3%3News Coverage1.52%MRNAModerna$41.11+7.5%4.5755 of 5 stars2.18$84.00 104.3%22Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume1.49%SNYSanofi$48.28+0.6%2.8092 of 5 stars2.75$57.50 19.1%41.46%INCYIncyte$71.72+1.9%3.9302 of 5 stars2.38$77.16 7.6%21Analyst Forecast1.44%SMMTSummit Therapeutics$19.00+3.1%1.8584 of 5 stars2.75$34.75 82.9%41.34%INSMInsmed$73.15-0.9%4.089 of 5 stars3.00$83.67 14.4%16Analyst ForecastNews Coverage1.33%NBIXNeurocrine Biosciences$125.65+0.5%4.9714 of 5 stars2.83$163.91 30.5%24Positive News1.27%BMRNBioMarin Pharmaceutical$64.26+1.3%4.9883 of 5 stars2.74$94.20 46.6%23Analyst Revision1.26%RPRXRoyalty Pharma$26.43+0.1%4.782 of 5 stars2.83$41.67 57.6%61.13%SRPTSarepta Therapeutics$114.23+3.4%4.9633 of 5 stars3.00$181.33 58.7%22Analyst Downgrade1.08%MEDPMedpace$337.75-1.2%4.7474 of 5 stars2.45$380.00 12.5%111.07%BNTXBioNTech$113.13+4.5%2.634 of 5 stars2.81$138.79 22.7%16Analyst Forecast1.06%EXELExelixis$35.61+2.2%4.7968 of 5 stars2.65$31.44 -11.7%20Insider TradeAnalyst RevisionPositive News1.03%PCVXVaxcyte$88.54+0.2%3.3258 of 5 stars3.00$147.50 66.6%7Positive News1.02%RVMDRevolution Medicines$56.75-0.1%2.8269 of 5 stars3.08$61.00 7.5%120.97%ITCIIntra-Cellular Therapies$85.69+0.3%4.4537 of 5 stars2.85$97.23 13.5%13Positive News0.93%BGNEBeiGene$190.51-2.1%3.1896 of 5 stars2.71$247.07 29.7%7Analyst Downgrade0.91%ROIVRoivant Sciences$12.53+6.0%3.337 of 5 stars2.88$17.93 43.1%8Insider Trade0.79%JAZZJazz Pharmaceuticals$126.67+1.3%4.8871 of 5 stars2.80$175.33 38.4%15Analyst ForecastNews CoverageGap Up0.77%ASNDAscendis Pharma A/S$129.81+5.8%2.9978 of 5 stars2.92$191.77 47.7%13Analyst Upgrade0.73%MDGLMadrigal Pharmaceuticals$347.45+5.5%3.6715 of 5 stars2.69$347.33 0.0%13Analyst Forecast0.64%BPMCBlueprint Medicines$94.15-2.6%2.7235 of 5 stars2.71$122.11 29.7%21Analyst Revision0.63%CYTKCytokinetics$49.10+3.0%4.042 of 5 stars2.75$83.93 70.9%16Analyst ForecastInsider TradeOptions Volume0.62%HALOHalozyme Therapeutics$49.00+7.2%4.9281 of 5 stars2.60$61.11 24.7%10Analyst ForecastNews CoverageGap UpHigh Trading Volume0.58%NUVLNuvalent$94.93+2.4%1.9519 of 5 stars2.85$112.60 18.6%130.55%KRYSKrystal Biotech$190.40+4.4%4.4435 of 5 stars3.00$202.29 6.2%8Positive News0.55%IONSIonis Pharmaceuticals$34.01+0.2%4.087 of 5 stars2.68$60.65 78.3%190.55%RNAAvidity Biosciences$43.25+1.6%2.1924 of 5 stars3.00$63.22 46.2%9Insider Trade0.53%ADMAADMA Biologics$21.18-0.6%3.128 of 5 stars3.25$21.25 0.3%4Insider Trade0.50%ACLXArcellx$90.44+3.7%2.9255 of 5 stars3.07$103.08 14.0%140.49%ALKSAlkermes$28.78+3.9%4.5585 of 5 stars2.58$35.42 23.1%12Positive News0.48%AXSMAxsome Therapeutics$98.68+0.5%4.6105 of 5 stars3.00$124.93 26.6%14Analyst Upgrade0.48%CRNXCrinetics Pharmaceuticals$56.06-1.7%3.5808 of 5 stars2.91$70.18 25.2%110.46%BBIOBridgeBio Pharma$23.42+0.8%4.5819 of 5 stars2.87$47.57 103.1%15Insider TradeNews Coverage0.46%RAREUltragenyx Pharmaceutical$47.24+2.7%4.5863 of 5 stars2.92$87.46 85.1%13Analyst Forecast0.43%CRSPCRISPR Therapeutics$47.88+3.4%1.4433 of 5 stars2.37$74.94 56.5%190.41%IMVTImmunovant$26.87+1.2%1.4585 of 5 stars3.00$48.10 79.0%11Insider TradeNews Coverage0.40%GHGuardant Health$32.65+5.4%3.9877 of 5 stars2.94$40.60 24.3%160.39%RYTMRhythm Pharmaceuticals$59.94+1.5%3.1421 of 5 stars2.90$62.30 3.9%10Analyst Forecast0.37%DNLIDenali Therapeutics$24.69+1.9%4.5108 of 5 stars2.73$38.90 57.6%11 This page (NASDAQ:IBBQ) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBBQ Stock Alerts